Q2 2026 Advanced Enzyme Technologies Ltd Earnings Call Transcript
Key Points
- Advanced Enzyme Technologies Ltd (BOM:540025) reported a 26% year-on-year revenue growth for Q2 FY26, reaching INR1,845 million.
- EBITDA increased by 42% year-on-year to INR601 million, with a margin of 33%.
- Profit after tax grew by 34% year-on-year to INR447 million, with a PAT margin of 24%.
- The Human Healthcare segment, the largest contributor, saw a 22% year-on-year revenue growth.
- The Bio-Processing segment recorded a strong 52% growth, driven by a 77% increase in the Food business year-on-year.
- Revenue slightly decreased by 1% quarter-on-quarter, from INR1,859 million to INR1,845 million.
- Animal Healthcare segment experienced a 26% decline quarter-on-quarter.
- The Non-Food business underperformed, with a 4% year-on-year decline and a 20% quarter-on-quarter decline.
- The company faces challenges due to tariff issues in the US, impacting growth expectations.
- There is uncertainty in maintaining the current growth trajectory due to global economic conditions and tariff impacts.
Good evening, ladies and gentlemen. I'm Akash, moderator for the conference call. Welcome to the Advanced Enzyme Technologies Limited Q2 and H1 FY26 earnings conference call. (Operator Instructions) Please note this conference is being recorded.
I would now like to hand over the floor to Mr. Ronak Saraf, Manager, Investor Relations. Thank you, and over to you, sir.
Thank you. Good evening, everyone. Welcome to the Advanced Enzyme Technologies Q2 and half year fY26 earnings conference call. We hope you all have gone through our financials, press release and the presentation, which has been posted in the Investor Relations section of our website and on stock exchanges.
We have with us Mr. Mukund Kabra, Whole-Time Director, and Mr. Beni Rauka, Group CFO. Today, the management will discuss the performance and the business highlights, update on strategies and respond to any questions that you may have.
As is usual, for the ease of discussion, we will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
